Professor and Division Head, Hematology and Medical Oncology, co-Deputy Director, Knight Cancer Insitute
Oregon Health & Science University
Upon completing her medical degree from Lady Hardinge Medical College in New Delhi, India, Dr. Shivaani Kummar moved to the United States to train in Internal Medicine at Emory University in Atlanta, Georgia. Following this, Dr. Kummar pursued fellowship training at the National Institute of Health (NIH) in Medical Oncology and Hematology, which culminated in a faculty position at Yale University, New Haven CT. After spending four years as Assistant Professor of Medicine at Yale Cancer Center, she moved back to the National Cancer Institute (NCI), NIH, where she developed a clinical research program in novel cancer therapeutics. In 2011, she became Head of Early Clinical Trials Development in the Office of the Director, Division of Cancer Treatment and Diagnosis, NCI. Dr. Kummar moved to Stanford University in 2015 as Professor of Medicine and Director of the Phase I Clinical Research and Translational Oncology Programs. In July 2020, she joined Oregon Health & Science University (OHSU) as Division Chief of Hematology and Medical Oncology, co-Director of the Center of Experimental Therapeutics, DeArmond Endowed Chair of Cancer Research, and is the co-Deputy Director, Knight Cancer Institute, OHSU. Her research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Dr. Kummar is the principal investigator of numerous early phase trials, member of NIH grant review committees and national and international scientific committees.
